<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/421B4793-37B1-4BD6-AAD9-8B6C240ED8C9"><gtr:id>421B4793-37B1-4BD6-AAD9-8B6C240ED8C9</gtr:id><gtr:name>Duke University</gtr:name><gtr:address><gtr:line1>Edmund T Pratt</gtr:line1><gtr:postCode>27708-0300</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FAA77269-CB2A-42CE-81EF-0E594636D7A2"><gtr:id>FAA77269-CB2A-42CE-81EF-0E594636D7A2</gtr:id><gtr:name>Avacta Group</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/95524E5B-E175-4691-AADA-C3E30E53A1F7"><gtr:id>95524E5B-E175-4691-AADA-C3E30E53A1F7</gtr:id><gtr:name>University of Cologne</gtr:name><gtr:address><gtr:line1>Fachbereich Wirtschaft</gtr:line1><gtr:line2>Claudrusstra?e 1</gtr:line2><gtr:line4>D-50678 Cologne</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C1CE3B13-A79B-48B7-9B8D-97BC9C07DC78"><gtr:id>C1CE3B13-A79B-48B7-9B8D-97BC9C07DC78</gtr:id><gtr:name>Netherlands Cancer Institute</gtr:name><gtr:address><gtr:line1>Plesmanlaan 121</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F93F6C72-B2CD-4D45-ADE1-581F814EA0BD"><gtr:id>F93F6C72-B2CD-4D45-ADE1-581F814EA0BD</gtr:id><gtr:name>Cancer Research Technology (CRT)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/38AAC27D-B957-44C3-A06A-8E19C2A33360"><gtr:id>38AAC27D-B957-44C3-A06A-8E19C2A33360</gtr:id><gtr:name>Forma Therapeutics</gtr:name><gtr:address><gtr:line1>NTU</gtr:line1><gtr:line2>SPMS-04-01</gtr:line2><gtr:line3>21 Nanyan Link</gtr:line3><gtr:postCode>637371</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1C7F479C-30BA-471A-AB0F-807BA3FABDC2"><gtr:id>1C7F479C-30BA-471A-AB0F-807BA3FABDC2</gtr:id><gtr:name>Frankfurt University</gtr:name><gtr:address><gtr:line1>Universitat Frankfurt</gtr:line1><gtr:line4>Frankfurt</gtr:line4><gtr:line5>D-60325</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/289F7529-FA9B-42C2-B4C7-4603DA25CC42"><gtr:id>289F7529-FA9B-42C2-B4C7-4603DA25CC42</gtr:id><gtr:name>Ludwig Institute for Cancer Research</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/38AAC27D-B957-44C3-A06A-8E19C2A33360"><gtr:id>38AAC27D-B957-44C3-A06A-8E19C2A33360</gtr:id><gtr:name>Forma Therapeutics</gtr:name><gtr:address><gtr:line1>NTU</gtr:line1><gtr:line2>SPMS-04-01</gtr:line2><gtr:line3>21 Nanyan Link</gtr:line3><gtr:postCode>637371</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/289F7529-FA9B-42C2-B4C7-4603DA25CC42"><gtr:id>289F7529-FA9B-42C2-B4C7-4603DA25CC42</gtr:id><gtr:name>Ludwig Institute for Cancer Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/421B4793-37B1-4BD6-AAD9-8B6C240ED8C9"><gtr:id>421B4793-37B1-4BD6-AAD9-8B6C240ED8C9</gtr:id><gtr:name>Duke University</gtr:name><gtr:address><gtr:line1>Edmund T Pratt</gtr:line1><gtr:postCode>27708-0300</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FAA77269-CB2A-42CE-81EF-0E594636D7A2"><gtr:id>FAA77269-CB2A-42CE-81EF-0E594636D7A2</gtr:id><gtr:name>Avacta Group</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/95524E5B-E175-4691-AADA-C3E30E53A1F7"><gtr:id>95524E5B-E175-4691-AADA-C3E30E53A1F7</gtr:id><gtr:name>University of Cologne</gtr:name><gtr:address><gtr:line1>Fachbereich Wirtschaft</gtr:line1><gtr:line2>Claudrusstra?e 1</gtr:line2><gtr:line4>D-50678 Cologne</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C1CE3B13-A79B-48B7-9B8D-97BC9C07DC78"><gtr:id>C1CE3B13-A79B-48B7-9B8D-97BC9C07DC78</gtr:id><gtr:name>Netherlands Cancer Institute</gtr:name><gtr:address><gtr:line1>Plesmanlaan 121</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F93F6C72-B2CD-4D45-ADE1-581F814EA0BD"><gtr:id>F93F6C72-B2CD-4D45-ADE1-581F814EA0BD</gtr:id><gtr:name>Cancer Research Technology (CRT)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1C7F479C-30BA-471A-AB0F-807BA3FABDC2"><gtr:id>1C7F479C-30BA-471A-AB0F-807BA3FABDC2</gtr:id><gtr:name>Frankfurt University</gtr:name><gtr:address><gtr:line1>Universitat Frankfurt</gtr:line1><gtr:line4>Frankfurt</gtr:line4><gtr:line5>D-60325</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4D6D513F-3E0A-4AE3-AAFB-F1D410CCCB5A"><gtr:id>4D6D513F-3E0A-4AE3-AAFB-F1D410CCCB5A</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Komander</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U105192732"><gtr:id>6BFAB0E4-DE17-4253-A6EF-B48375F95BBF</gtr:id><gtr:title>Specificity in the ubiquitin system</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U105192732</gtr:grantReference><gtr:abstractText>The cells in our body need to respond to signals of many kinds, and adapt appropriately to ever changing environments. This is achieved to some extent by direct modification of cellular proteins. Closer examination reveals that virtually every cellular protein is regulated by modifications, which regulate its the life-time, activity, interactions with other proteins, and its localisation within the cell.
Our programme studies one such modification, named ubiquitination. This process has in recent years emerged as a central mechanism to relay signals in response to signals, in particular to a wide variety of stress such as DNA damage, or infection. Importantly, a large number of human diseases, from cancer to infection and inflammation, emerge when the ubiquitin system is disturbed. 
At this stage of research, much mechanistic detail of the process itself has to be uncovered. We are planning to gain insight into the molecular mechanism behind ubiquitination, by using biochemical and structural biology methods to understand this process at the atomic level. A number of the studied proteins are direct regulators of disease, and hence atomic structure information might aid in the development of novel drugs.</gtr:abstractText><gtr:technicalSummary>Protein ubiquitination emerges as a key regulatory posttranslational modification, which is utilised both in degradative processes regulating the half-life of target proteins, as well as in signal transduction where it serves non-degradative functions. 
During ubiquitination, the small protein ubiquitin is attached covalently to target proteins. Ubiquitin can be ubiquitinated itself, generating ubiquitin polymers. The versatility of the ubiquitin system is achieved by the ability of ubiquitin to form at least eight types of polymers, and proteomic analysis has shown that all different ubiquitin linkages are present in cells. To date, functional and structural data is available for only three types of polyubiquitin chains. These are the well-studied Lys48-linked polyubiquitin chain, that targets modified proteins for proteasomal degradation, as well as Lys63-linked polyubiquitin that are implicated in cell signalling processes. Independent functions for the remaining chain types are emerging. 
We aim to generate and study the remaining ubiquitin chain types, and understand their roles in the cell. For this, we need to study ubiquitin chain assembly systems. This work has led us to determine the structure of the E3 ubiquitin ligase Parkin, explaining many mutations of individuals with early-onset Parkinson?s disease, shedding new light on the role of ubiquitin in neurodegenerative disorders. 
Moreover, we have identified E2 and E3 enzymes to generate Lys6- and Lys11-linked polyubiquitin chains. Availability of novel chain linkages is important to understand the molecular basis for specificity in the ubiquitin system, especially specificity of deubiquitinases and ubiquitin binding domains. 
Deubiquitinating enzymes hydrolyse ubiquitin chains, and are therefore key regulators of the ubiquitin system. Currently, limited information is available as how this important class of enzymes is regulated. We perform structural and functional studies on deubiquitinases of the Ovarian Tumour family, to understand how they affect cell signalling pathways at the molecular level.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-06-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>6386380</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Klenerman / Jackson labs</gtr:description><gtr:id>EAA827AE-DD67-4E41-8409-74D8FDA052B2</gtr:id><gtr:impact>published paper: 
Ye et al, Nature 2012</gtr:impact><gtr:outcomeId>gNRxY342fQq-1</gtr:outcomeId><gtr:partnerContribution>The Klenerman and Jackson labs have excellent single molecule expertise and apparatus which we use to gain insight into our biological systems.</gtr:partnerContribution><gtr:piContribution>We have an ongoing collaboration applying single molecule methods (at the Chemistry Dept) to the ubiquitin system (our area and contribution).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Medicine</gtr:department><gtr:description>DUB Alliance</gtr:description><gtr:id>CCDBBE39-7B8F-4972-AA38-9767B2D6DC1B</gtr:id><gtr:impact>no non-confidential research outputs as of yet.</gtr:impact><gtr:outcomeId>EZuoy6uUE74-4</gtr:outcomeId><gtr:partnerContribution>target identification, lead discovery, SAR, crystallography, in vivo validation, phase 1 clinical trials</gtr:partnerContribution><gtr:piContribution>This Alliance, led by CRT, has set as an aim to develop small molecule inhibitors for deubiquitinases. 
The Alliance will fund a scientist in my lab to contribute to the effort.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Geography and Planning</gtr:department><gtr:description>bacterial effectors</gtr:description><gtr:id>784AD393-0296-40E7-B369-671B15541FF4</gtr:id><gtr:impact>paper in preparation</gtr:impact><gtr:outcomeId>58c7e42c54d0a7.07671706-2</gtr:outcomeId><gtr:partnerContribution>the partners provide cell biological insights (U Liv) and microbiology insights (Duke)</gtr:partnerContribution><gtr:piContribution>We work on bacterial effector mechanisms and structure</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research Technology (CRT)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>DUB Alliance</gtr:description><gtr:id>72D6B6F9-01B2-4CED-867B-9C4AE18CAEFC</gtr:id><gtr:impact>no non-confidential research outputs as of yet.</gtr:impact><gtr:outcomeId>EZuoy6uUE74-1</gtr:outcomeId><gtr:partnerContribution>target identification, lead discovery, SAR, crystallography, in vivo validation, phase 1 clinical trials</gtr:partnerContribution><gtr:piContribution>This Alliance, led by CRT, has set as an aim to develop small molecule inhibitors for deubiquitinases. 
The Alliance will fund a scientist in my lab to contribute to the effort.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Avacta Group</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Affimer collaboration</gtr:description><gtr:id>BF4AAFFF-7064-41D6-BF52-6D98C7F30D89</gtr:id><gtr:impact>A first paper is in preparation, for submission in summer 2016.</gtr:impact><gtr:outcomeId>56dd9fc8c353b2.02326866-1</gtr:outcomeId><gtr:partnerContribution>Avacta LifeSciences has a novel technology to evolve a small proteins scaffold to bind protein targets with very high affinity. They have generated reagents that we were seeking, and upon testing, we engaged in a fully-fleshed collaboration.</gtr:partnerContribution><gtr:piContribution>We have access to new research reagents through a collaboration with Avacta LifeSciences, which has resulted in generating new insights into the ubiquitin system. The collaboration is restricted to ubiquitin and ubiquitin chain specific reagents, which we receive from Avcacta and characterise structurally, biochemically and in cell biologically. A first paper is planned on these new tools. Once we help improve reagents, MRC LMB will benefit through royalty payments.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Netherlands Cancer Institute (NKI)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>DUB Alliance</gtr:description><gtr:id>A213296A-E064-4304-A95C-6625C921E252</gtr:id><gtr:impact>no non-confidential research outputs as of yet.</gtr:impact><gtr:outcomeId>EZuoy6uUE74-5</gtr:outcomeId><gtr:partnerContribution>target identification, lead discovery, SAR, crystallography, in vivo validation, phase 1 clinical trials</gtr:partnerContribution><gtr:piContribution>This Alliance, led by CRT, has set as an aim to develop small molecule inhibitors for deubiquitinases. 
The Alliance will fund a scientist in my lab to contribute to the effort.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ludwig Institute for Cancer Research</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Oxford Branch</gtr:department><gtr:description>Gyrd-Hansen lab</gtr:description><gtr:id>B5B7B908-583A-4F2F-A040-68E13D668EE9</gtr:id><gtr:impact>Keusekotten et al, Cell 2013
Fiil et al, Mol Cell 2013
Elliott et al, submitted</gtr:impact><gtr:outcomeId>bbpRXqJ1E9h-1</gtr:outcomeId><gtr:partnerContribution>- technical expertise and analysis
- know-how
- generating large amounts of data for publications.</gtr:partnerContribution><gtr:piContribution>We collaborated with the labs of Mads Gyrd-Hansen on the cellular role of OTULIN, a new deubiquitinase we discovered in humans. 
The Gyrd-Hansen lab recently relocated to Oxford, from Copenhagen.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Netherlands Cancer Institute (NKI)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Chemical Biology Laboratory</gtr:department><gtr:description>ubiquitin chemical biology</gtr:description><gtr:id>4530B17C-175B-43F7-AF59-9A8716D10A9D</gtr:id><gtr:impact>several papers published in 2013.
Mevissen et al, Cell 2013
Ekkebus et al, JACS 2013
1 paper published: Licchesi et al, NSMB 2012.</gtr:impact><gtr:outcomeId>JXXycHH5DNq-1</gtr:outcomeId><gtr:partnerContribution>Huib Ovaa lab assembles Ub chains as substrates for our assays, and ubiquitin suicide probes as chemical modifiers for deubiquitinases.</gtr:partnerContribution><gtr:piContribution>We collaborate with the team of Dr Huib Ovaa at NKI Amsterdam to analyse linkage specificity of deubiquitinases. using the tools provided by the Ovaa group, we were able to discover linkage-specificity in a family of human deubiquitinases. Furthermore, some different tools helped us to determine crystal structures of previously inaccessible protein complexes</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Duke University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>bacterial effectors</gtr:description><gtr:id>C6921512-9231-4D08-8DF4-D3C140D95546</gtr:id><gtr:impact>paper in preparation</gtr:impact><gtr:outcomeId>58c7e42c54d0a7.07671706-1</gtr:outcomeId><gtr:partnerContribution>the partners provide cell biological insights (U Liv) and microbiology insights (Duke)</gtr:partnerContribution><gtr:piContribution>We work on bacterial effector mechanisms and structure</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Frankfurt</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Institute for Biochemistry II</gtr:department><gtr:description>Collaboration on the role of linear ubiquitin chains in NFkB signalling</gtr:description><gtr:id>23E98FD0-739F-461B-88A2-F4FFC2FDD659</gtr:id><gtr:impact>The results were pubished in 2 high-profile papers:
a) Rahighi et al, Cell 2009 (collaboration Frankfurt)
b) Haas et al, Mol Cell (Collaboration Imperial)</gtr:impact><gtr:outcomeId>MEaAWhrxsFG-2</gtr:outcomeId><gtr:partnerContribution>We collaborated to understand the role of linear ubiquitin chains in TNF signallingWe collaborated on the role of linear ubiquitin chain binding to NEMO</gtr:partnerContribution><gtr:piContribution>We provided reagents in form of ubiquitin chains and expertise</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Life Sciences Liverpool</gtr:department><gtr:description>DUB Alliance</gtr:description><gtr:id>63DD8606-3A71-4323-B5C0-AFDC7A6C62B4</gtr:id><gtr:impact>no non-confidential research outputs as of yet.</gtr:impact><gtr:outcomeId>EZuoy6uUE74-3</gtr:outcomeId><gtr:partnerContribution>target identification, lead discovery, SAR, crystallography, in vivo validation, phase 1 clinical trials</gtr:partnerContribution><gtr:piContribution>This Alliance, led by CRT, has set as an aim to develop small molecule inhibitors for deubiquitinases. 
The Alliance will fund a scientist in my lab to contribute to the effort.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Collaboration on the role of linear ubiquitin chains in NFkB signalling</gtr:description><gtr:id>68C5AA10-B6EF-400F-92B8-028181C66D0B</gtr:id><gtr:impact>The results were pubished in 2 high-profile papers:
a) Rahighi et al, Cell 2009 (collaboration Frankfurt)
b) Haas et al, Mol Cell (Collaboration Imperial)</gtr:impact><gtr:outcomeId>MEaAWhrxsFG-1</gtr:outcomeId><gtr:partnerContribution>We collaborated to understand the role of linear ubiquitin chains in TNF signallingWe collaborated on the role of linear ubiquitin chain binding to NEMO</gtr:partnerContribution><gtr:piContribution>We provided reagents in form of ubiquitin chains and expertise</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cologne</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Institute for Genetics</gtr:department><gtr:description>Hofmann lab</gtr:description><gtr:id>7558FD6A-C95D-4588-91A6-FB0C7DB058DE</gtr:id><gtr:impact>published papers:
Ye et al, Mol BioSyst 2009
Kulathu et al, NSMB 2009 
Keusekotten et al, Cell 2013</gtr:impact><gtr:outcomeId>XRRaUfn374D-1</gtr:outcomeId><gtr:partnerContribution>bioinformatical predictions of deubiquitinases and other proteins int he ubiquitin system</gtr:partnerContribution><gtr:piContribution>We collaborate with the bioinformatics group of Prof Kay Hofmann, who has provided great insights and predictions on the DUBs in humans and bacterial species.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>FORMA Therapeutics</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>DUB Alliance</gtr:description><gtr:id>58D1F505-C462-4C4E-8706-420AE2E2DFCE</gtr:id><gtr:impact>no non-confidential research outputs as of yet.</gtr:impact><gtr:outcomeId>EZuoy6uUE74-2</gtr:outcomeId><gtr:partnerContribution>target identification, lead discovery, SAR, crystallography, in vivo validation, phase 1 clinical trials</gtr:partnerContribution><gtr:piContribution>This Alliance, led by CRT, has set as an aim to develop small molecule inhibitors for deubiquitinases. 
The Alliance will fund a scientist in my lab to contribute to the effort.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>visit to Parliament - Rune Damgaard / Marie Curie Fellowship event</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>ED091EE9-09D4-4242-8828-46800F99B2C7</gtr:id><gtr:impact>Rune Damgaard participated in his role as an Marie Curie Fellow in an event at the British Parliament in London, to speak to MPs and policymakers about the benefit of European Funding, freedom of movement and mobility, for his own career and UK science. 
Rune was one of two selected fellows from Marie Curie Fellowship, and one of 20 invited experts.</gtr:impact><gtr:outcomeId>58c7e5bb9c4c05.62089538</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk to Trade &amp; Investment Officers from British Embassies</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>194A05C7-AE2D-418C-92E1-1708C31E438D</gtr:id><gtr:impact>I was chosen to present LMB to Trade &amp;amp; Investment Officers from British Embassies and discussed with them our activities - not only research but also eg drug discovery. Afterwards, I had plenty of interest from officers from the US and Germany. Officers realised the power of our location in Cambridge as ideal for research and technology.

We represented MRC and LMB and altered them of our work.</gtr:impact><gtr:outcomeId>54638312e5a072.85549097</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Outreach events in Belfast - Rune Damgaard</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9A9A4BD3-C161-4776-AA44-67AC56FBEBEC</gtr:id><gtr:impact>Rune Damgaard visited Belfast to present his work in basic biological research to a school audience, to trigger interest of pupils in a career in science.</gtr:impact><gtr:outcomeId>58c7e51c835630.93830172</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview on our research on ubiquitin in disease.</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>591A426C-D5CD-4032-AD5D-2AB78DFABC66</gtr:id><gtr:impact>We were interviewed by a scientific writer writing for the American Society of Biochemistry and Molecular Biology (ASBMB) to contribute to a piece about our recent research on OTULIN and linear ubiquitin chains in human disease. In 2016, we published a Cell paper in which we discovered a new human disease. While this was not covered by MRC press offices, it is nice that the American colleagues picked this up and gave it the deserved platform.</gtr:impact><gtr:outcomeId>58c7e6ccdf6bd8.73801173</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:url>http://www.asbmb.org/asbmbtoday/201701/Feature/ChainOfEvents/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dr P. Marco-Casanova: Cambridge Science Festival / MRC LMB Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1FB2B659-2193-497F-8B99-93A75959D2A8</gtr:id><gtr:impact>These activities were about teaching kids to use microscopes and doing preparations of their own cheek cells to look at them under the microscope. Dr Paola Marco-Casanova participated in the events that were organised by Dr Rodrigo-Brenni from MRC LMB. 


- generate awareness of cell biology and science in young pupils
- represent MRC scientists to the general public</gtr:impact><gtr:outcomeId>ETVWdgx61Xp</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Workshop - Understanding Protein-Ubiquitin Interactions</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>282300FD-D55A-4CDD-A5CC-86E4B4AE61A0</gtr:id><gtr:impact>Results

Impacts</gtr:impact><gtr:outcomeId>5460f0240a7481.12216688</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Lister Prize</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Lister Institute of Preventive Medicine</gtr:fundingOrg><gtr:fundingRef>n/a</gtr:fundingRef><gtr:id>C845B2CE-3A49-4332-B158-FACBEB2A80D6</gtr:id><gtr:outcomeId>aZyXmSHs2dj</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>DFG Postdoctoral Research Fellowship</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>German Research Foundation (DFG)</gtr:fundingOrg><gtr:id>DE355BDF-DA3B-4E23-AF57-746B840F79BC</gtr:id><gtr:outcomeId>ebYHLwM4gEW0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>52000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMBO Long Term Fellowship - Pruneda</gtr:description><gtr:end>2015-07-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation</gtr:fundingOrg><gtr:fundingRef>EMBO ALTF 589-2013</gtr:fundingRef><gtr:id>55B1AD6A-CE16-4BA7-A3CA-77EAE3DDB0AF</gtr:id><gtr:outcomeId>Pi7Q4f3BzAS</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2013-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>179619</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Marie Curie Initial Training Network</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Marie Sklodowska-Curie Actions</gtr:fundingOrg><gtr:id>E94AD44D-800E-47A1-BFEE-625790A57381</gtr:id><gtr:outcomeId>TQtEHJjCjyF0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Erasmus Plus - Bompadre</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>erasmus +</gtr:fundingOrg><gtr:id>B09AC210-8A3F-4307-8542-E5300F5C14C2</gtr:id><gtr:outcomeId>58bd843e45bbd1.52428501</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>55000</gtr:amountPounds><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:currCode>CHF</gtr:currCode><gtr:currCountryCode>Switzerland</gtr:currCountryCode><gtr:currLang>it_CH</gtr:currLang><gtr:description>SNSF Studentship - Michel</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>Swiss National Science Foundation</gtr:fundingOrg><gtr:id>0D45ECE8-B06A-42C9-8B6B-369088723D22</gtr:id><gtr:outcomeId>58c03e0f311fe6.54434249</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2017-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>180103</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Marie Curie Long Term Fellowship - Kulathu</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Marie Sklodowska-Curie Actions</gtr:fundingOrg><gtr:fundingRef>FP7-People-2009-IEF-253389</gtr:fundingRef><gtr:id>08F8D8D2-7B13-4FBD-9119-C982302D0C18</gtr:id><gtr:outcomeId>fzA5f5dHnFS0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>183455</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Horizon 2020</gtr:department><gtr:description>Marie Sklodowska-Curie Long Term Fellowship Damgaard</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>H2020-MSCA-IF-2014-654019</gtr:fundingRef><gtr:id>F02E0CCA-84CD-4AC6-A391-C4612473668D</gtr:id><gtr:outcomeId>56dcbd1e5211e7.75296851</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>392961</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>DUBs Alliance</gtr:description><gtr:end>2018-06-02</gtr:end><gtr:fundingOrg>Cancer Research Technology (CRT)</gtr:fundingOrg><gtr:id>5D1E0C31-1FC1-4F3A-B8F1-B05D372E177D</gtr:id><gtr:outcomeId>5460fd4e960d58.95720278</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4500000</gtr:amountPounds><gtr:country>Japan</gtr:country><gtr:currCode>JPY</gtr:currCode><gtr:currCountryCode>Japan</gtr:currCountryCode><gtr:currLang>ja_JP</gtr:currLang><gtr:description>Fellowship - Shibata</gtr:description><gtr:end>2018-04-02</gtr:end><gtr:fundingOrg>Naito Foundation</gtr:fundingOrg><gtr:id>3BC6A685-7389-4F5C-8C78-E9A5859AE581</gtr:id><gtr:outcomeId>58bd7eaa028669.20986622</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>8500</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMBO Young Investigator Programme</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation</gtr:fundingOrg><gtr:id>9B22EECA-5519-48EC-AD7B-593B77938C00</gtr:id><gtr:outcomeId>MhKsc3gG6BN0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1480285</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>ERC Starting Grant</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:fundingRef>ERC-20120-StG-309756</gtr:fundingRef><gtr:id>CC0AC167-1721-4F2F-8C44-307F8C89871E</gtr:id><gtr:outcomeId>HcM24MRKoP8</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Lister Studentship</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Lister Institute of Preventive Medicine</gtr:fundingOrg><gtr:id>C7456309-D95E-455F-9F0D-F0A568D49EFE</gtr:id><gtr:outcomeId>58bd88746fe836.37255950</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMBO Long Term Fellowship - Kulathu</gtr:description><gtr:end>2013-01-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation</gtr:fundingOrg><gtr:id>04C9C2BB-2602-4B01-B2C7-BDFECE74B3EE</gtr:id><gtr:outcomeId>LWJPf533ibb0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>This reagent is a polymer of ubiquitin molecules linked via an isopeptide bond to Lys11 (K11). This was generated by protein engineering of an K11-assembly enzyme.</gtr:description><gtr:id>40C4AA6A-839D-4DED-8401-EC47FCF0B3D4</gtr:id><gtr:impact>K11-linked ubiquitin chains are a novel signal in cells involved in the cell cycle. We have been the first to generate this material in large quantities. This will be useful to identify new cell cycle regulators which may be involved in cancer.</gtr:impact><gtr:outcomeId>qL5aFBF7T14</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>K11-linked polyubiquitin</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed an enzymatic assembly method for Lys6-linked polyubiquitin. This is described in Hospenthal et al, NSMB 2013.</gtr:description><gtr:id>1717789E-8005-4F65-B2FB-4414CE188DF9</gtr:id><gtr:impact>This enabled research on the unstudied posttranslational modification of Lys6-linked polyubiquitin.</gtr:impact><gtr:outcomeId>kzb1EUYt1Uy</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>K6-linked polyUb (enzymatic)</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We generated a suite of linkage-specific OTU DUBs that are sued in Ub chain restriction analysis. 
These enzymes have been evaluated by a leading Ubiquitin reagent supplier for a fee.</gtr:description><gtr:id>5B4DD3D3-78C6-4EF2-999A-34852E63081D</gtr:id><gtr:impact>many collaborations started</gtr:impact><gtr:outcomeId>PjXjp2CaKGK</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>OTU DUBs</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>ubiquitin molecules linked via K6 (1) or K29 (2) into a diubiquitin. this was generated by chemical synthesis described in Virdee et al, Nat Chem Biol 2009.</gtr:description><gtr:id>BCE74D44-3687-4262-98A6-E75084E6ABA5</gtr:id><gtr:impact>K6- and K29-linked polyubiquitin exist in cells but their function is unknown. With this material we have been able to identify a specific enzyme that cleaves the K29-linked ubiquitin chains specifically. These reagents have not been available before.</gtr:impact><gtr:outcomeId>FF2RWFwWbgU</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>K6 and K29-linked diubiquitin</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Fluorescence based assay for deubiquitinase enzymes. Patented UK application no. 1009941.4. Licensed by Boston Biochem.</gtr:description><gtr:id>917F73CD-DA26-4DFD-A839-3A72C546B004</gtr:id><gtr:impact>New assay to generate fluorescence output from DUB activity. Goes beyond current assays as diubiquitin is the substrate. useful for DUB drug discovery.</gtr:impact><gtr:outcomeId>546373dc0da3e7.53586072</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>DUB assay</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have discovered a class of human deubiquitinating enzymes that can be used analytically to study the type and topology of ubiquitin chains on a substrate. The discovered deubiquitinases have different properties and specificities. This will allow ubiquitin chain sequencing, which we believe may become an important future tool in biochemical studies. 
UPDATE: Boston Biochem has licensed this technology, and is now selling it.</gtr:description><gtr:id>213382F5-F0A7-4444-845E-2B8C0B772851</gtr:id><gtr:impact>This method will allow quick and easy assessment of the Ub chain types present on a protein. this is currently a challenging but very important problem.</gtr:impact><gtr:outcomeId>ktyniXVYPvC</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>ubiquitin chain restriction analysis (UbiCRest)</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://www.bostonbiochem.com/ubicrest-technology-exclusively-licensed-boston-biochem-laboratory-prof-david-komander</gtr:url><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>4BC3B5DA-DF9B-48B4-B828-C16D9D897D17</gtr:id><gtr:title>Mechanism and regulation of the Lys6-selective deubiquitinase USP30.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8401ce1250fb8c79622c61ceb289843a"><gtr:id>8401ce1250fb8c79622c61ceb289843a</gtr:id><gtr:otherNames>Gersch M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>5a9d1f8c4b2d22.31617047</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1AF359B-F15C-433E-8E8C-8170331A8DD0</gtr:id><gtr:title>A further case of Dop-ing in bacterial pupylation.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72967a28d7c9d42dd28f5c962c343b3d"><gtr:id>72967a28d7c9d42dd28f5c962c343b3d</gtr:id><gtr:otherNames>Bremm A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>jyrWVnkb41F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B53B17DE-CDF7-4906-BF49-75D7B3166332</gtr:id><gtr:title>Regulation of A20 and other OTU deubiquitinases by reversible oxidation.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0803e4d4d17426709f097fca759a45a5"><gtr:id>0803e4d4d17426709f097fca759a45a5</gtr:id><gtr:otherNames>Kulathu Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pm_15391_21_23463012</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4226DFB-9730-4861-9747-BED989954D4A</gtr:id><gtr:title>Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c53d69d72e6fc8262835558471c36b24"><gtr:id>c53d69d72e6fc8262835558471c36b24</gtr:id><gtr:otherNames>Haas TL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>gPVXZ1B4yq6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>655E0969-2023-433E-8DB5-780103561945</gtr:id><gtr:title>Efficient APC/C substrate degradation in cells undergoing mitotic exit depends on K11 ubiquitin linkages.</gtr:title><gtr:parentPublicationTitle>Molecular biology of the cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/816ef8b1b2073b67a9afcf678ca5a97f"><gtr:id>816ef8b1b2073b67a9afcf678ca5a97f</gtr:id><gtr:otherNames>Min M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1059-1524</gtr:issn><gtr:outcomeId>56dcbb3a7df907.18318725</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C18F95E-FB16-4F05-86AB-669E7ED32C47</gtr:id><gtr:title>The nuts and bolts of AGC protein kinases.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Molecular cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04805c136fdc80831b34653a2466319a"><gtr:id>04805c136fdc80831b34653a2466319a</gtr:id><gtr:otherNames>Pearce LR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-0072</gtr:issn><gtr:outcomeId>kJ2ZjMVwqpG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A46DA638-7C18-4B6A-911A-71C436899F06</gtr:id><gtr:title>Structure of the human Parkin ligase domain in an autoinhibited state.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d5ad81e08e6f789d4d47ea8114f16df"><gtr:id>4d5ad81e08e6f789d4d47ea8114f16df</gtr:id><gtr:otherNames>Wauer T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>pm_15391_21_23727886</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7ADA27F-FC48-4CC9-90E2-C2AFF5490A5F</gtr:id><gtr:title>OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d05b1253812d48f3f2dacc1124a6089"><gtr:id>2d05b1253812d48f3f2dacc1124a6089</gtr:id><gtr:otherNames>Mevissen TE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>pm_15391_21_23827681</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7EE6F140-FF0C-4AAF-872E-725E50C70C9D</gtr:id><gtr:title>Ubiquitin-Mediated Regulation of RIPK1 Kinase Activity Independent of IKK and MK2.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/258cf8ff51b8d2a3263bfa2c95b0e33a"><gtr:id>258cf8ff51b8d2a3263bfa2c95b0e33a</gtr:id><gtr:otherNames>Annibaldi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>5aaa8e2e2ec0f6.85795236</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A23D52CC-C769-45A8-9A68-66FBCE56DE5B</gtr:id><gtr:title>LC3C, bound selectively by a noncanonical LIR motif in NDP52, is required for antibacterial autophagy.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00cc2f346d241d5a78282d5a90944082"><gtr:id>00cc2f346d241d5a78282d5a90944082</gtr:id><gtr:otherNames>von Muhlinen N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>pm_15391_21_23022382</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7BA3BAE-4BD9-41DC-B9DB-FBADCA18F32E</gtr:id><gtr:title>The Molecular Basis for Ubiquitin and Ubiquitin-like Specificities in Bacterial Effector Proteases.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39488b97c9b412f2140f459df22c5c08"><gtr:id>39488b97c9b412f2140f459df22c5c08</gtr:id><gtr:otherNames>Pruneda JN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>58bd7a4a8327f8.55862718</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC10D0CE-CFAE-4CDC-807B-D8E37F3D8EA4</gtr:id><gtr:title>Synthesis of Poly-Ubiquitin Chains Using a Bifunctional Ubiquitin Monomer.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34000e4886a4da640c9728e7ab8443b9"><gtr:id>34000e4886a4da640c9728e7ab8443b9</gtr:id><gtr:otherNames>van der Heden van Noort GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>5a9d1f8d370303.48325528</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B16C9166-36DF-4302-9DF0-73A5B582920D</gtr:id><gtr:title>The tumour suppressor CYLD regulates the p53 DNA damage response.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e69e5ed794b20be773859b6392b493ac"><gtr:id>e69e5ed794b20be773859b6392b493ac</gtr:id><gtr:otherNames>Fern?ndez-Majada V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>58bd7a48c06947.08636057</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14E28FE9-0151-460C-9357-E2A4E8D8DFFE</gtr:id><gtr:title>Lys11-linked ubiquitin chains adopt compact conformations and are preferentially hydrolyzed by the deubiquitinase Cezanne.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72967a28d7c9d42dd28f5c962c343b3d"><gtr:id>72967a28d7c9d42dd28f5c962c343b3d</gtr:id><gtr:otherNames>Bremm A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>mfRKTjv4qhL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB97E86F-88A0-40DC-A72C-1CD40C432233</gtr:id><gtr:title>A Linear Diubiquitin-Based Probe for Efficient and Selective Detection of the Deubiquitinating Enzyme OTULIN.</gtr:title><gtr:parentPublicationTitle>Cell chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/501c50f9f60bb207070e587ef133986a"><gtr:id>501c50f9f60bb207070e587ef133986a</gtr:id><gtr:otherNames>Weber A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2451-9448</gtr:issn><gtr:outcomeId>5a9d1f8be0dc59.36738009</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D38D1E0-2F75-4A0A-BD33-3A0828884FFB</gtr:id><gtr:title>Analysis of the human E2 ubiquitin conjugating enzyme protein interaction network.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94e17d68f41abc56eb35c8340d5ef7bb"><gtr:id>94e17d68f41abc56eb35c8340d5ef7bb</gtr:id><gtr:otherNames>Markson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn><gtr:outcomeId>bXa92zmU1rd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA2361A5-25E7-4632-BF88-6016F0B4F1DC</gtr:id><gtr:title>Assembly and specific recognition of k29- and k33-linked polyubiquitin.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a067dd340d36444ea1ea5b1eaf14707"><gtr:id>8a067dd340d36444ea1ea5b1eaf14707</gtr:id><gtr:otherNames>Michel MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>56dcbb3a33e136.23634972</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>168C71B3-0FEA-4051-B0F1-4A9D549E54EF</gtr:id><gtr:title>Polyubiquitin binding and cross-reactivity in the USP domain deubiquitinase USP21.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8fee6c56dd4e0c00b65d2d47ee4b5ec4"><gtr:id>8fee6c56dd4e0c00b65d2d47ee4b5ec4</gtr:id><gtr:otherNames>Ye Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>doExyJtA5e7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69CDDF28-3673-43B8-98DD-4479E80DAEC6</gtr:id><gtr:title>The JAMM in the proteasome.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d5ad81e08e6f789d4d47ea8114f16df"><gtr:id>4d5ad81e08e6f789d4d47ea8114f16df</gtr:id><gtr:otherNames>Wauer T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>5460f26f6f4f42.83359905</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8EBCB48-A720-440A-80A7-1EE5333EEBDE</gtr:id><gtr:title>Mechanisms of Deubiquitinase Specificity and Regulation.</gtr:title><gtr:parentPublicationTitle>Annual review of biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37ae5794f8b7fce46009d3ff9409a792"><gtr:id>37ae5794f8b7fce46009d3ff9409a792</gtr:id><gtr:otherNames>Mevissen TET</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0066-4154</gtr:issn><gtr:outcomeId>5a9d1f8bbb63b1.53915714</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69004C38-D4FD-458D-8F24-B2506D6ACE6C</gtr:id><gtr:title>Breaking the chains: structure and function of the deubiquitinases.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Molecular cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46a1d0cdedcc95ccf3122feac0e4ff79"><gtr:id>46a1d0cdedcc95ccf3122feac0e4ff79</gtr:id><gtr:otherNames>Komander D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-0072</gtr:issn><gtr:outcomeId>WuRcfmQJ6TW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2AE6173-627E-4AA6-82C0-CAC02E170940</gtr:id><gtr:title>Molecular basis and regulation of OTULIN-LUBAC interaction.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ba0334bcd9992d53572a43b9c6da5d9"><gtr:id>0ba0334bcd9992d53572a43b9c6da5d9</gtr:id><gtr:otherNames>Elliott PR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>5460f26fbfc886.06850904</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CD8F689-75A0-4747-9CFE-6E23C55583F4</gtr:id><gtr:title>Molecular basis for ubiquitin and ISG15 cross-reactivity in viral ovarian tumor domains.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd0ba717aa19b7e3aacb0b7350f4566c"><gtr:id>fd0ba717aa19b7e3aacb0b7350f4566c</gtr:id><gtr:otherNames>Akutsu M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>sx3B7LWc6UJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34E6F54A-8752-4CEC-B26B-31FDAF8C2995</gtr:id><gtr:title>Strange New World: Bacteria Catalyze Ubiquitylation via ADP Ribosylation.</gtr:title><gtr:parentPublicationTitle>Cell host &amp; microbe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46a1d0cdedcc95ccf3122feac0e4ff79"><gtr:id>46a1d0cdedcc95ccf3122feac0e4ff79</gtr:id><gtr:otherNames>Komander D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1931-3128</gtr:issn><gtr:outcomeId>58bd7a4822df22.54203256</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88C5642A-B592-4E5F-B267-E04C155D5AA9</gtr:id><gtr:title>Recruitment of TBK1 to cytosol-invading Salmonella induces WIPI2-dependent antibacterial autophagy.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05002b2ae2918b805d6e22be00852b31"><gtr:id>05002b2ae2918b805d6e22be00852b31</gtr:id><gtr:otherNames>Thurston TL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>585d3fc48c3449.26442957</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06854EB8-2ABE-4875-A97A-414B36EA02B5</gtr:id><gtr:title>Emerging roles for Lys11-linked polyubiquitin in cellular regulation.</gtr:title><gtr:parentPublicationTitle>Trends in biochemical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72967a28d7c9d42dd28f5c962c343b3d"><gtr:id>72967a28d7c9d42dd28f5c962c343b3d</gtr:id><gtr:otherNames>Bremm A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0968-0004</gtr:issn><gtr:outcomeId>DmY8eJEDncv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25BAB8CF-3A6A-4E4E-B46D-5D8189F88442</gtr:id><gtr:title>An ankyrin-repeat ubiquitin-binding domain determines TRABID's specificity for atypical ubiquitin chains.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/82611df54c3ff0653b2e0226cb3539e9"><gtr:id>82611df54c3ff0653b2e0226cb3539e9</gtr:id><gtr:otherNames>Licchesi JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>pm_15391_21_22157957</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0DD7EEB-1415-48E1-883D-1D2B94E4A4D5</gtr:id><gtr:title>CYLD tidies up dishevelled signaling.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46a1d0cdedcc95ccf3122feac0e4ff79"><gtr:id>46a1d0cdedcc95ccf3122feac0e4ff79</gtr:id><gtr:otherNames>Komander D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>rU8csSBwBDB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>284247D9-6FEE-4F72-951F-88752C456EA5</gtr:id><gtr:title>The emerging complexity of protein ubiquitination.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46a1d0cdedcc95ccf3122feac0e4ff79"><gtr:id>46a1d0cdedcc95ccf3122feac0e4ff79</gtr:id><gtr:otherNames>Komander D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>XFvkZJXG46m</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4EB7EB1-994F-4441-8B49-0381CC69C553</gtr:id><gtr:title>Ubiquitin chain conformation regulates recognition and activity of interacting proteins.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8fee6c56dd4e0c00b65d2d47ee4b5ec4"><gtr:id>8fee6c56dd4e0c00b65d2d47ee4b5ec4</gtr:id><gtr:otherNames>Ye Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_15391_21_23201676</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13EC3888-30F4-4AA9-9C41-83B620718734</gtr:id><gtr:title>Structure of PINK1 in complex with its substrate ubiquitin.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d68e0c504e4e498a010e04911c85819b"><gtr:id>d68e0c504e4e498a010e04911c85819b</gtr:id><gtr:otherNames>Schubert AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5a9d1f8d023fe6.61175237</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F2782A0-5754-492B-8B4F-0128F019575A</gtr:id><gtr:title>Cezanne regulates E2F1-dependent HIF2a expression.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9fd53151fc9f23333363d0fea8a94d7"><gtr:id>f9fd53151fc9f23333363d0fea8a94d7</gtr:id><gtr:otherNames>Moniz S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>56dcbb3aa85da4.40230797</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFB56A2B-C232-4C73-A7D1-AF180DD1D5B8</gtr:id><gtr:title>BIM(EL), an intrinsically disordered protein, is degraded by 20S proteasomes in the absence of poly-ubiquitylation.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f42c59dbfc698614694d0c06081ec05a"><gtr:id>f42c59dbfc698614694d0c06081ec05a</gtr:id><gtr:otherNames>Wiggins CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>YxsrrRor3KX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD82EE2E-25FD-4D62-9DC7-5168FEEBA55A</gtr:id><gtr:title>The ubiquitin code.</gtr:title><gtr:parentPublicationTitle>Annual review of biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46a1d0cdedcc95ccf3122feac0e4ff79"><gtr:id>46a1d0cdedcc95ccf3122feac0e4ff79</gtr:id><gtr:otherNames>Komander D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0066-4154</gtr:issn><gtr:outcomeId>pm_15391_21_22524316</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF476721-D3AD-4AB9-875E-00FC43C66BB7</gtr:id><gtr:title>Gsk3? and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e7565294ff60f126e4f23ff9e6a8d92"><gtr:id>9e7565294ff60f126e4f23ff9e6a8d92</gtr:id><gtr:otherNames>Teixeira FR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>58bd7a49cda4b7.33179298</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E61A5B7C-E417-46F7-8004-5C1B1D2F31E6</gtr:id><gtr:title>The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b096e8aa0cd785493d0ffa073dbb71b9"><gtr:id>b096e8aa0cd785493d0ffa073dbb71b9</gtr:id><gtr:otherNames>Damgaard RB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>58bd7a4a4c8867.48876796</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B8A9491-DAF5-43DA-8F2F-9FC8B4E46FD0</gtr:id><gtr:title>Mechanism of phospho-ubiquitin-induced PARKIN activation.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d5ad81e08e6f789d4d47ea8114f16df"><gtr:id>4d5ad81e08e6f789d4d47ea8114f16df</gtr:id><gtr:otherNames>Wauer T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56dcbb3b084373.97841186</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17AEAB8D-EE24-46BD-AEF7-951789256B28</gtr:id><gtr:title>SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ba0334bcd9992d53572a43b9c6da5d9"><gtr:id>0ba0334bcd9992d53572a43b9c6da5d9</gtr:id><gtr:otherNames>Elliott PR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>58bd7a4a1215c5.40262104</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A7970EF-E8AD-4205-A855-DFFAF4685B40</gtr:id><gtr:title>Non-hydrolyzable Diubiquitin Probes Reveal Linkage-Specific Reactivity of Deubiquitylating Enzymes Mediated by S2 Pockets.</gtr:title><gtr:parentPublicationTitle>Cell chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b5db85e2a994ccdac00a1fb116245d8"><gtr:id>2b5db85e2a994ccdac00a1fb116245d8</gtr:id><gtr:otherNames>Flierman D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2451-9448</gtr:issn><gtr:outcomeId>58bd7a496d61d1.15767172</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9ABD8DDD-7B19-4123-AF12-278B5CED9A0D</gtr:id><gtr:title>Development of Diubiquitin-Based FRET Probes To Quantify Ubiquitin Linkage Specificity of Deubiquitinating Enzymes.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abea7c2dd30c5b71950d374f468bc0d5"><gtr:id>abea7c2dd30c5b71950d374f468bc0d5</gtr:id><gtr:otherNames>Geurink PP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>58bd7a493e6e94.73909572</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34D94A2A-73BC-45C2-95E3-C4DD10264B82</gtr:id><gtr:title>Biochemistry. Details of destruction, one molecule at a time.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46a1d0cdedcc95ccf3122feac0e4ff79"><gtr:id>46a1d0cdedcc95ccf3122feac0e4ff79</gtr:id><gtr:otherNames>Komander D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>56dcbb3a1326f3.78468059</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F11D0C04-376A-41FF-9755-A94FE3AF627E</gtr:id><gtr:title>A cascading activity-based probe sequentially targets E1-E2-E3 ubiquitin enzymes.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3ec768df3dfedf523627e3f653e4996"><gtr:id>e3ec768df3dfedf523627e3f653e4996</gtr:id><gtr:otherNames>Mulder MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>58bd7a4902e517.68799115</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90C00543-6B5B-437C-BDB8-F4E4C9A46899</gtr:id><gtr:title>Regulation of Met1-linked polyubiquitin signalling by the deubiquitinase OTULIN.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ba0334bcd9992d53572a43b9c6da5d9"><gtr:id>0ba0334bcd9992d53572a43b9c6da5d9</gtr:id><gtr:otherNames>Elliott PR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>56dcbb39dd3902.85024296</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84765C7B-F923-4C2D-ABDA-E702C9653396</gtr:id><gtr:title>Cezanne (OTUD7B) regulates HIF-1a homeostasis in a proteasome-independent manner.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72967a28d7c9d42dd28f5c962c343b3d"><gtr:id>72967a28d7c9d42dd28f5c962c343b3d</gtr:id><gtr:otherNames>Bremm A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>5460f26f457236.74251841</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6A0A2BC-DEC6-43F5-A334-8B7A96F7B346</gtr:id><gtr:title>Ubiquitin Linkage-Specific Affimers Reveal Insights into K6-Linked Ubiquitin Signaling.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a067dd340d36444ea1ea5b1eaf14707"><gtr:id>8a067dd340d36444ea1ea5b1eaf14707</gtr:id><gtr:otherNames>Michel MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>5a9d1f8c1b3b86.55982167</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F469799-FB81-4771-889D-F7373C490174</gtr:id><gtr:title>OTULIN restricts Met1-linked ubiquitination to control innate immune signaling.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc69cac080aa82c23b8a5b680216cedd"><gtr:id>fc69cac080aa82c23b8a5b680216cedd</gtr:id><gtr:otherNames>Fiil BK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>pm_15391_21_23806334</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFC5D6D5-586A-4A5A-AC9C-6A3430E10BB3</gtr:id><gtr:title>New tools for ubiquitin signaling.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ecf5197101c6ac55e0e4906c66cfd7c"><gtr:id>7ecf5197101c6ac55e0e4906c66cfd7c</gtr:id><gtr:otherNames>Keusekotten K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>pm_15391_21_22381406</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08DB0E5A-7057-4DA2-B315-948F843B8011</gtr:id><gtr:title>Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42c5535937f784a4c0ad3bc626073c7e"><gtr:id>42c5535937f784a4c0ad3bc626073c7e</gtr:id><gtr:otherNames>Emmerich CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_15391_21_23986494</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80BF0041-9A49-45EF-AF9C-FCEB1CC60A1E</gtr:id><gtr:title>Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46a1d0cdedcc95ccf3122feac0e4ff79"><gtr:id>46a1d0cdedcc95ccf3122feac0e4ff79</gtr:id><gtr:otherNames>Komander D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>WDA8RPgdtqd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8D8AC50-45E5-4C21-A0F2-E454A20F1499</gtr:id><gtr:title>Synthesis and analysis of K11-linked ubiquitin chains.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72967a28d7c9d42dd28f5c962c343b3d"><gtr:id>72967a28d7c9d42dd28f5c962c343b3d</gtr:id><gtr:otherNames>Bremm A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>5460f43ad197f3.41946123</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7272630D-6F3C-4225-AB9A-EA4BC9208D93</gtr:id><gtr:title>On terminal alkynes that can react with active-site cysteine nucleophiles in proteases.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/afc1381badd2ae57ad965de137c871b9"><gtr:id>afc1381badd2ae57ad965de137c871b9</gtr:id><gtr:otherNames>Ekkebus R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>pm_15391_21_23387960</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A833C35-F7DA-4013-B06E-0D82700A8ACD</gtr:id><gtr:title>Molecular basis of USP7 inhibition by selective small-molecule inhibitors.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36964180502b2515d94e253e3dc3caf8"><gtr:id>36964180502b2515d94e253e3dc3caf8</gtr:id><gtr:otherNames>Turnbull AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5a9d1f8c89cd03.10667694</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7506639A-E62D-46BB-8678-81AE048A34A2</gtr:id><gtr:title>OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ecf5197101c6ac55e0e4906c66cfd7c"><gtr:id>7ecf5197101c6ac55e0e4906c66cfd7c</gtr:id><gtr:otherNames>Keusekotten K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>pm_15391_21_23746843</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02A24568-1593-4AEC-86CA-411ED9FC1C50</gtr:id><gtr:title>Deubiquitinase-based analysis of ubiquitin chain architecture using Ubiquitin Chain Restriction (UbiCRest).</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3dd554981a3b581e34b16efb5f30f2c9"><gtr:id>3dd554981a3b581e34b16efb5f30f2c9</gtr:id><gtr:otherNames>Hospenthal MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>56dcbbea6393f3.60104610</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2A876FE-4533-4270-B06C-51304BE7BBB1</gtr:id><gtr:title>Molecular basis for specificity of the Met1-linked polyubiquitin signal.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ba0334bcd9992d53572a43b9c6da5d9"><gtr:id>0ba0334bcd9992d53572a43b9c6da5d9</gtr:id><gtr:otherNames>Elliott PR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>58bd7b202f8e27.82970076</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50DAA186-CAC8-429C-B864-E807B162667B</gtr:id><gtr:title>Assembly, analysis and architecture of atypical ubiquitin chains.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3dd554981a3b581e34b16efb5f30f2c9"><gtr:id>3dd554981a3b581e34b16efb5f30f2c9</gtr:id><gtr:otherNames>Hospenthal MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>pm_15391_21_23563141</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>011B87C0-C299-4D5B-9B5E-0CEDCE4D17EF</gtr:id><gtr:title>Lysine 27 ubiquitination of the mitochondrial transport protein Miro is dependent on serine 65 of the Parkin ubiquitin ligase.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af2d5f2e04b285bdff9667c446ba5cae"><gtr:id>af2d5f2e04b285bdff9667c446ba5cae</gtr:id><gtr:otherNames>Birsa N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>5460f26f997377.97021403</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D940B2D-BE12-4319-80F8-453AAFE59167</gtr:id><gtr:title>Molecular basis of Lys11-polyubiquitin specificity in the deubiquitinase Cezanne.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37ae5794f8b7fce46009d3ff9409a792"><gtr:id>37ae5794f8b7fce46009d3ff9409a792</gtr:id><gtr:otherNames>Mevissen TET</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>58bd7a4891f193.98871050</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>090E308B-816E-4788-BE24-04DC9E75A405</gtr:id><gtr:title>Irreversible inactivation of ISG15 by a viral leader protease enables alternative infection detection strategies.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19f77131302f7664e11867a4dacb73dd"><gtr:id>19f77131302f7664e11867a4dacb73dd</gtr:id><gtr:otherNames>Swatek KN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5aaa8e2e684e86.68296737</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72ADA030-5149-440D-86AB-2A7BCC0BA44B</gtr:id><gtr:title>CYLD Limits Lys63- and Met1-Linked Ubiquitin at Receptor Complexes to Regulate Innate Immune Signaling.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abc0835a255f21da0855cbc0f157696c"><gtr:id>abc0835a255f21da0855cbc0f157696c</gtr:id><gtr:otherNames>Hrdinka M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58bd7a499a36a0.07256709</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D02A0C3-FFAF-4BCF-B875-E798F5DE4E73</gtr:id><gtr:title>Two-sided ubiquitin binding explains specificity of the TAB2 NZF domain.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0803e4d4d17426709f097fca759a45a5"><gtr:id>0803e4d4d17426709f097fca759a45a5</gtr:id><gtr:otherNames>Kulathu Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>cUCh5WwRaKY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17800A78-CEF9-48B0-BC89-E03182E8EA76</gtr:id><gtr:title>LUBAC-synthesized linear ubiquitin chains restrict cytosol-invading bacteria by activating autophagy and NF-?B.</gtr:title><gtr:parentPublicationTitle>Nature microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/776865bd1cfe7d3382c3fab74b3e1955"><gtr:id>776865bd1cfe7d3382c3fab74b3e1955</gtr:id><gtr:otherNames>Noad J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2058-5276</gtr:issn><gtr:outcomeId>5a9d1f8b889161.42624746</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC1A64AB-069D-4745-83D2-CC5BFCC4ECA0</gtr:id><gtr:title>Dissection of USP catalytic domains reveals five common insertion points.</gtr:title><gtr:parentPublicationTitle>Molecular bioSystems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8fee6c56dd4e0c00b65d2d47ee4b5ec4"><gtr:id>8fee6c56dd4e0c00b65d2d47ee4b5ec4</gtr:id><gtr:otherNames>Ye Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1742-2051</gtr:issn><gtr:outcomeId>UDKMwnnBfpo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9A526F3-F5C6-4D1F-8DBB-B1D86E992E4C</gtr:id><gtr:title>An essential role for the ATG8 ortholog LC3C in antibacterial autophagy.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00cc2f346d241d5a78282d5a90944082"><gtr:id>00cc2f346d241d5a78282d5a90944082</gtr:id><gtr:otherNames>von Muhlinen N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>pm_15391_21_23434839</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC3EF1DF-9AF4-4D87-8730-EB57B66BC6AE</gtr:id><gtr:title>The Salmonella Effector SpvD Is a Cysteine Hydrolase with a Serovar-specific Polymorphism Influencing Catalytic Activity, Suppression of Immune Responses, and Bacterial Virulence.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1055e5acc1a80b93bac3fe32004b3518"><gtr:id>1055e5acc1a80b93bac3fe32004b3518</gtr:id><gtr:otherNames>Grabe GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>58bd7a485dfcf5.31831455</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA2E7CE9-6BE7-4C29-9310-FEDE15A005D4</gtr:id><gtr:title>Ubiquitin modifications.</gtr:title><gtr:parentPublicationTitle>Cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19f77131302f7664e11867a4dacb73dd"><gtr:id>19f77131302f7664e11867a4dacb73dd</gtr:id><gtr:otherNames>Swatek KN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1001-0602</gtr:issn><gtr:outcomeId>58bd7a4b074485.14940436</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>245205C3-9154-4DF4-B1BB-40DBA47097C4</gtr:id><gtr:title>Erratum: Mechanism of phospho-ubiquitin-induced PARKIN activation.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d5ad81e08e6f789d4d47ea8114f16df"><gtr:id>4d5ad81e08e6f789d4d47ea8114f16df</gtr:id><gtr:otherNames>Wauer T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>58bd7a4abd0cd0.12513476</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A607B2D7-D62B-4A51-94B5-85A583B1C36D</gtr:id><gtr:title>Engineered diubiquitin synthesis reveals Lys29-isopeptide specificity of an OTU deubiquitinase.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cfc759e7a1860bf17500dcf3b9ad276"><gtr:id>5cfc759e7a1860bf17500dcf3b9ad276</gtr:id><gtr:otherNames>Virdee S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>TN2y8bggaci</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D1E6769-0C89-400D-A3BE-A3CC0E97C3F1</gtr:id><gtr:title>Atypical ubiquitylation - the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Molecular cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0803e4d4d17426709f097fca759a45a5"><gtr:id>0803e4d4d17426709f097fca759a45a5</gtr:id><gtr:otherNames>Kulathu Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-0072</gtr:issn><gtr:outcomeId>pm_15391_21_22820888</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3DA32A8-19D0-4232-B522-3F321EDA291C</gtr:id><gtr:title>An invisible ubiquitin conformation is required for efficient phosphorylation by PINK1.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa0a9e97d6b2dd7f0a75b39615f4a7fa"><gtr:id>aa0a9e97d6b2dd7f0a75b39615f4a7fa</gtr:id><gtr:otherNames>Gladkova C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>5a9d1f8cc31522.43213132</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>460C5717-9247-497E-A9C3-C516516664C3</gtr:id><gtr:title>Ubiquitin Ser65 phosphorylation affects ubiquitin structure, chain assembly and hydrolysis.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d5ad81e08e6f789d4d47ea8114f16df"><gtr:id>4d5ad81e08e6f789d4d47ea8114f16df</gtr:id><gtr:otherNames>Wauer T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>56dcbb3ad131e0.00924037</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E167DF9A-6E35-4B29-B41C-5969EE850341</gtr:id><gtr:title>Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b53ca1b998e826c908ce6d8bc7c6c15"><gtr:id>6b53ca1b998e826c908ce6d8bc7c6c15</gtr:id><gtr:otherNames>Rahighi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>RqU9oJoExJe</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U105192732</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>